These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20229259)

  • 1. Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis.
    Inoue D; Arima H; Kawanami C; Takiuchi Y; Nagano S; Kimura T; Shimoji S; Mori M; Tabata S; Yanagita S; Matsushita A; Nagai K; Imai Y; Takahashi T
    Clin Rheumatol; 2010 Oct; 29(10):1195-7. PubMed ID: 20229259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis.
    Okuda Y; Takasugi K
    Arthritis Rheum; 2006 Sep; 54(9):2997-3000. PubMed ID: 16947531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amyloidosis of the small intestine secondary to rheumatoid arthritis and juvenile rheumatoid arthritis: report of two cases].
    Hashimoto M; Shingu M; Yoshikawa Y; Nonaka S; Wada T; Ichibanngase Y; Nobunaga M
    Ryumachi; 1995 Feb; 35(1):100-6. PubMed ID: 7732482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis.
    Sato H; Sakai T; Sugaya T; Otaki Y; Aoki K; Ishii K; Horizono H; Otani H; Abe A; Yamada N; Ishikawa H; Nakazono K; Murasawa A; Gejyo F
    Clin Rheumatol; 2009 Sep; 28(9):1113-6. PubMed ID: 19437089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocilizumab improves cardiac disease in a hemodialysis patient with AA amyloidosis secondary to rheumatoid arthritis.
    Hattori Y; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Hoshino J; Sawa N; Oohashi K; Takaichi K
    Amyloid; 2012 Mar; 19(1):37-40. PubMed ID: 22260742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
    Miyagawa I; Nakayamada S; Saito K; Hanami K; Nawata M; Sawamukai N; Nakano K; Yamaoka K; Tanaka Y
    Mod Rheumatol; 2014 May; 24(3):405-9. PubMed ID: 24252016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature.
    Jung JY; Kim YB; Kim JW; Suh CH; Kim HA
    Medicine (Baltimore); 2021 Aug; 100(32):e26843. PubMed ID: 34397890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab preserves renal function in rheumatoid arthritis with AA amyloidosis and end-stage kidney disease: Two case reports.
    Fukuda M; Sawa N; Hoshino J; Ohashi K; Motoaki M; Ubara Y
    Clin Nephrol; 2021 Jan; 95(1):54-61. PubMed ID: 33155543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report.
    Yamagata A; Uchida T; Yamada Y; Nakanishi T; Nagai K; Imakiire T; Oshima N; Kumagai H
    BMC Nephrol; 2017 Dec; 18(1):377. PubMed ID: 29287589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of gastrointestinal amyloidosis and hypoproteinemia improved by tocilizumab].
    Dainaka K; Isozaki Y; Kunieda K; Takayama S; Mukai R; Yamada N; Morimoto Y; Nagao Y; Oyamada H; Kawabata K
    Nihon Shokakibyo Gakkai Zasshi; 2016; 113(2):245-53. PubMed ID: 26853984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
    Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy.
    Nishimoto N; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Azuma J; Kishimoto T
    Mod Rheumatol; 2009; 19(1):12-9. PubMed ID: 18979150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
    Yamada Y; Ueno T; Irifuku T; Nakashima A; Doi S; Ichinohe T; Masaki T
    Clin Nephrol; 2018 Sep; 90(3):232-236. PubMed ID: 29701172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab.
    Kuroda T; Otaki Y; Sato H; Fujimura T; Nakatsue T; Murakami S; Sakatsume M; Nakano M; Gejyo F
    Rheumatol Int; 2008 Sep; 28(11):1155-9. PubMed ID: 18496698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple ulcers in the small and large intestines occurred during tocilizumab therapy for rheumatoid arthritis.
    Iwasa T; Nakamura K; Ogino H; Itaba S; Akiho H; Okamoto R; Iboshi Y; Aso A; Murao H; Kanayama K; Ito T; Takayanagi R
    Endoscopy; 2011 Jan; 43(1):70-2. PubMed ID: 21108178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive Multifocal Leukoencephalopathy during Tocilizumab Treatment for Rheumatoid Arthritis.
    Anada M; Tohyama M; Oda Y; Kamoshima Y; Amino I; Nakano F; Miyazaki Y; Akimoto S; Minami N; Kikuchi S; Terae S; Niino M
    Intern Med; 2020 Aug; 59(16):2053-2059. PubMed ID: 32448834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of blocking IL-6 receptor.
    Mima T; Nishimoto N
    Curr Opin Rheumatol; 2009 May; 21(3):224-30. PubMed ID: 19365268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Treatment of Rheumatoid Arthritis-Associated Renal AA Amyloidosis with Tocilizumab.
    Kovács A; Cserenyecz A; Baksay B; Kemény É; Szekanecz Z
    Isr Med Assoc J; 2020 Jul; 22(7):455-457. PubMed ID: 33236574
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.
    Genovese MC; McKay JD; Nasonov EL; Mysler EF; da Silva NA; Alecock E; Woodworth T; Gomez-Reino JJ
    Arthritis Rheum; 2008 Oct; 58(10):2968-80. PubMed ID: 18821691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.